Study protocol for a multicenter, multinational, observational registry of epidemiology, treatment and outcome of patients with Robin sequence

Abstract Background Robin sequence (RS) is a congenital condition characterized by micrognathia, glossoptosis and upper airway obstruction. Diagnosis and treatment are characterized by heterogeneity, resulting in a lack of uniformly collected data. Methods We have set up a prospective, observational...

Full description

Bibliographic Details
Main Authors: Anna-Lisa Oechsle, Cornelia Wiechers, Veronique Abadie, Francois Abel, Corstiaan Breugem, Christian F. Poets
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Head & Face Medicine
Subjects:
Online Access:https://doi.org/10.1186/s13005-023-00364-3
_version_ 1797822605616480256
author Anna-Lisa Oechsle
Cornelia Wiechers
Veronique Abadie
Francois Abel
Corstiaan Breugem
Christian F. Poets
author_facet Anna-Lisa Oechsle
Cornelia Wiechers
Veronique Abadie
Francois Abel
Corstiaan Breugem
Christian F. Poets
author_sort Anna-Lisa Oechsle
collection DOAJ
description Abstract Background Robin sequence (RS) is a congenital condition characterized by micrognathia, glossoptosis and upper airway obstruction. Diagnosis and treatment are characterized by heterogeneity, resulting in a lack of uniformly collected data. Methods We have set up a prospective, observational, multicenter, multinational registry aimed at obtaining routine clinical data from RS patients receiving different treatment approaches and enabling an assessment of outcomes obtained through different therapeutic approaches. Patient enrolment has started in January 2022. Disease characteristics, adverse events and complications depending on the different diagnostic and treatment approaches and their effects on neurocognition, growth, speech development and hearing outcome are evaluated using routine clinical data. In addition to characterizing the patient population and comparing outcomes achieved with different treatment approaches, the registry will evolve to focus on endpoints such as quality of life and long-term developmental status. Discussion This registry will provide data on different treatment approaches collected during routine care with diverse framework conditions and will allow assessing diagnostic and therapeutic outcomes of children with RS. These data, urgently demanded by the scientific community, may contribute to refining and personalizing existing therapeutic approaches and increase knowledge about the long-term outcome of children born with this rare condition. Trial registration DRKS00025365.
first_indexed 2024-03-13T10:11:35Z
format Article
id doaj.art-71858326288c468590fd7c3c0714dd40
institution Directory Open Access Journal
issn 1746-160X
language English
last_indexed 2024-03-13T10:11:35Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Head & Face Medicine
spelling doaj.art-71858326288c468590fd7c3c0714dd402023-05-21T11:28:30ZengBMCHead & Face Medicine1746-160X2023-05-011911710.1186/s13005-023-00364-3Study protocol for a multicenter, multinational, observational registry of epidemiology, treatment and outcome of patients with Robin sequenceAnna-Lisa Oechsle0Cornelia Wiechers1Veronique Abadie2Francois Abel3Corstiaan Breugem4Christian F. Poets5Interdisciplinary Center for Cleft Palate & Craniofacial Malformations, Department of Neonatology, Tübingen University HospitalInterdisciplinary Center for Cleft Palate & Craniofacial Malformations, Department of Neonatology, Tübingen University HospitalDepartment of General Pediatrics, Reference Centre for Rare Diseases ’Pierre Robin sequences and congenital sucking-swallowing troubles’, Necker University Hospital, Paris UniversityDepartment of Pediatric Respiratory Medicine, Great Ormond Street HospitalDepartment of Plastic Reconstructive and Hand Surgery, Emma Children’s Hospital - Location AMC, Amsterdam UMC, University of AmsterdamInterdisciplinary Center for Cleft Palate & Craniofacial Malformations, Department of Neonatology, Tübingen University HospitalAbstract Background Robin sequence (RS) is a congenital condition characterized by micrognathia, glossoptosis and upper airway obstruction. Diagnosis and treatment are characterized by heterogeneity, resulting in a lack of uniformly collected data. Methods We have set up a prospective, observational, multicenter, multinational registry aimed at obtaining routine clinical data from RS patients receiving different treatment approaches and enabling an assessment of outcomes obtained through different therapeutic approaches. Patient enrolment has started in January 2022. Disease characteristics, adverse events and complications depending on the different diagnostic and treatment approaches and their effects on neurocognition, growth, speech development and hearing outcome are evaluated using routine clinical data. In addition to characterizing the patient population and comparing outcomes achieved with different treatment approaches, the registry will evolve to focus on endpoints such as quality of life and long-term developmental status. Discussion This registry will provide data on different treatment approaches collected during routine care with diverse framework conditions and will allow assessing diagnostic and therapeutic outcomes of children with RS. These data, urgently demanded by the scientific community, may contribute to refining and personalizing existing therapeutic approaches and increase knowledge about the long-term outcome of children born with this rare condition. Trial registration DRKS00025365.https://doi.org/10.1186/s13005-023-00364-3Robin sequenceRegistryDatabaseRare diseaseOutcome
spellingShingle Anna-Lisa Oechsle
Cornelia Wiechers
Veronique Abadie
Francois Abel
Corstiaan Breugem
Christian F. Poets
Study protocol for a multicenter, multinational, observational registry of epidemiology, treatment and outcome of patients with Robin sequence
Head & Face Medicine
Robin sequence
Registry
Database
Rare disease
Outcome
title Study protocol for a multicenter, multinational, observational registry of epidemiology, treatment and outcome of patients with Robin sequence
title_full Study protocol for a multicenter, multinational, observational registry of epidemiology, treatment and outcome of patients with Robin sequence
title_fullStr Study protocol for a multicenter, multinational, observational registry of epidemiology, treatment and outcome of patients with Robin sequence
title_full_unstemmed Study protocol for a multicenter, multinational, observational registry of epidemiology, treatment and outcome of patients with Robin sequence
title_short Study protocol for a multicenter, multinational, observational registry of epidemiology, treatment and outcome of patients with Robin sequence
title_sort study protocol for a multicenter multinational observational registry of epidemiology treatment and outcome of patients with robin sequence
topic Robin sequence
Registry
Database
Rare disease
Outcome
url https://doi.org/10.1186/s13005-023-00364-3
work_keys_str_mv AT annalisaoechsle studyprotocolforamulticentermultinationalobservationalregistryofepidemiologytreatmentandoutcomeofpatientswithrobinsequence
AT corneliawiechers studyprotocolforamulticentermultinationalobservationalregistryofepidemiologytreatmentandoutcomeofpatientswithrobinsequence
AT veroniqueabadie studyprotocolforamulticentermultinationalobservationalregistryofepidemiologytreatmentandoutcomeofpatientswithrobinsequence
AT francoisabel studyprotocolforamulticentermultinationalobservationalregistryofepidemiologytreatmentandoutcomeofpatientswithrobinsequence
AT corstiaanbreugem studyprotocolforamulticentermultinationalobservationalregistryofepidemiologytreatmentandoutcomeofpatientswithrobinsequence
AT christianfpoets studyprotocolforamulticentermultinationalobservationalregistryofepidemiologytreatmentandoutcomeofpatientswithrobinsequence